Latest Commercialisation News

1414 Degrees Ltd advances its transformation into a full-service decarbonised energy provider, delivering key technology and commercial milestones in Q3 FY25 while maintaining a stable cash position.

Vectus Biosystems advances its lead fibrosis drug VB0004 with validated Phase I safety data and strategic cost reductions, while actively pursuing licensing partnerships in China.

BPH Global Ltd has raised $609,000 through a targeted placement and made significant strides in its Indonesian seaweed venture, including binding offtake agreements and R&D breakthroughs on mineral extraction.

Kinetiko Energy reports encouraging progress in South African gas exploration, with improved well performance and a drilling optimisation study revealing key production enhancements.

Australian Rare Earths Limited (ASX: AR3) has secured a $5 million government grant to advance its Koppamurra Rare Earths Project, confirmed promising uranium mineralisation at its Overland Project, and raised $3.6 million through a rights issue to accelerate development.

KALiNA Power has advanced its Canadian AI data centre power portfolio with strategic site sales, partnerships, and a $1.5 million capital raise to fund development milestones.

Green Critical Minerals has fast-tracked its VHD Graphite pilot plant commissioning, producing prototype blocks with record-breaking density and thermal performance, while securing strategic partnerships and advancing key projects.

TrivarX has launched a pivotal mental health clinical trial in partnership with the US Department of Veterans Affairs, leveraging its innovative ECG-based technology to screen for major depressive episodes. The company also secured $2.25 million in funding, positioning it for regulatory milestones ahead.

Strategic Elements Ltd (ASX: SOR) reported meaningful progress in its Energy Ink™ technology and underground mining platform during Q1 2025, while maintaining a robust cash balance and preparing for international collaborations.

Avecho Biotechnology has inked a decade-long exclusive licensing agreement with Sandoz for its pharmaceutical-grade cannabidiol capsule targeting insomnia in Australia, backed by a US$3 million upfront payment and promising milestone and royalty streams.

QPM Energy Limited has announced a significant 31% upgrade to its Moranbah Gas Project's 2P reserves, now certified at 435PJ, reinforcing the asset's status as a tier 1 gas resource with substantial uncontracted volumes.

IPB Petroleum Limited has secured a crucial two-year extension on its WA-424-P permit in the Browse Basin, enabling continued exploration and development of its Gwydion asset while maintaining a solid cash position of AUD 1.487 million.